No Data
No Data
Metagenomi to Present at the 2024 Jefferies Global Healthcare Conference
EMERYVILLE, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (NASDAQ:MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive
Express News | HC Wainwright & Co. Reiterates Buy on Metagenomi, Maintains $10 Price Target
Express News | Metagenomi Technologies LLC : Jefferies Cuts Target Price to $21 From $22
Express News | Metagenomi Q1 2024 Adj EPS $(1.19) Misses $(0.78) Estimate
Express News | Metagenomi Inc: Cash Runway Anticipated to Support Anticipated Operating Plans Into 2027
Metagenomi Technologies, LLC | 10-Q: Quarterly report
No Data